SkinnyRx

What it is

Patients complete an online intake and a licensed provider decides whether to prescribe.

FDA's February 2026 warning letter describes the company's website as offering compounded semaglutide and tirzepatide products.

SkinnyRx's sitemap lists a sermorelin injectable product page (updated September 2026).

The product page loads in the browser only, so its price and terms could not be read in this check.

No NAD+ product was found.

Prescribes: Compounded semaglutide and tirzepatide (not FDA-approved), per FDA's description of the website. Compounded sermorelin (not FDA-approved) and GLP-1s.

What it costs

Insurance: Not stated on the company pages that could be loaded.

Prices change often. Check skinnyrx.com before you sign up.

By the numbers

• Trustpilot 4.7/5 from 5,446 reviews (4% 1-star; Trustpilot marks many recent reviews as invited; checked 2026-10-15).4

Pros and cons

What users say

Common themes in public posts on Reddit, Trustpilot, the Better Business Bureau and app stores, summarised and linked. Individual experiences vary.

• Reviewers often praise patient, helpful staff and a smooth sign-up and refill process.2
• Some reviewers report slow or missed callbacks and that the oral medication did not curb appetite for them.2
• SkinnyRx is discussed on Reddit mainly for its oral compounded GLP-1 tablets; commenters are sceptical that oral compounded tirzepatide works and recommend injections instead, and one member said the tablets did not work for them.789
• A September 2025 thread describes paying for a full subscription up front and a long cancellation flow; replies suggest a card chargeback and confirm the support line does answer after a hold.9
• On Trustpilot, where Trustpilot labels many recent reviews as invited, reviewers praise patient, helpful staff and easy refills; negative reviews say the medication did not help, callbacks did not happen and sales calls continued after declining.4
• Reviewers praise patient staff and easy sign-up and refills.2
• Some report slow callbacks; none seen mention sermorelin.2

Records we found

Official and court records we found in public sources as of October 15, 2026. This is not a live or complete record; check fda.gov, ftc.gov and court sites for the latest.

1. Feb 2026
   FDA

   FDA sent a warning letter to Lean Rx, Inc. dba SkinnyRx stating that website claims, including that its compounded products contain the same active ingredient as FDA-approved medications and labels identifying SkinnyRx as if it were the compounder, were false or misleading and rendered the drugs misbranded.1

2. Feb 2026
   FDA

   FDA warning letter citing 'same active ingredient' claims and labels presenting SkinnyRx as the compounder (GLP-1s, not sermorelin).1